Glucokinase Activator in Monogenic Diabetes

A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.

NCT00437606 ·Status: TERMINATED ·Phase: PHASE1

Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus

NCT02589639 ·Status: COMPLETED ·Phase: PHASE4

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

NCT02528019 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes

NCT00856908 ·Status: COMPLETED ·Phase: PHASE2

Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes

NCT05629806 ·Status: UNKNOWN ·Phase: PHASE3

Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA

NCT02589626 ·Status: COMPLETED ·Phase: PHASE4

A Safety Study of ARRY-403 in Patients With Type 2 Diabetes

NCT00859755 ·Status: COMPLETED ·Phase: PHASE1

Dose Response Study in Japanese Patients

NCT00261417 ·Status: TERMINATED ·Phase: PHASE2

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin

NCT00768105 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes

NCT03315780 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate How Well Single and Multiple Doses of GLPG3121-modified Release Formulation Are Tolerated in Healthy, Adult Subjects

NCT04856358 ·Status: COMPLETED ·Phase: PHASE1

A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

NCT06263348 ·Status: RECRUITING ·Phase: PHASE4

Phase III Insulin Add-On Asia Regional Program - ST

NCT02096705 ·Status: COMPLETED ·Phase: PHASE3

A Prospective, Observational Study to Assess and Evaluate the Use of Glucophage XR Therapy in the Management of Patients With Type 2 Diabetes

NCT01117103 ·Status: COMPLETED

Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes

NCT06007014 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Drug Interaction Study of SLM0807 and HKB0701 in Healthy Subjects

NCT01039896 ·Status: COMPLETED ·Phase: PHASE1

Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects

NCT01690169 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

NCT01013766 ·Status: COMPLETED ·Phase: PHASE1

Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment

NCT00213109 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control

NCT00621140 ·Status: COMPLETED ·Phase: PHASE3

To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes

NCT01176097 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes

NCT00857558 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin

NCT04233801 ·Status: COMPLETED ·Phase: PHASE3

Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus

NCT01947855 ·Status: COMPLETED ·Phase: PHASE3

Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.

NCT02157298 ·Status: COMPLETED ·Phase: PHASE4